Welcome to EQUITY DEVELOPMENT
The UK's longest established regulated provider of sponsored equity research.
We launched EQUITY DEVELOPMENT in 1997 becoming the first ever regulated provider of Sponsored Equity Research in the UK.
Our research teams are made up of expert analysts with deep understanding & experience in their sectors. Our research is distributed to all relevant investment classes & commentators. (at no cost to the reader).
We have made our name by specialising in those companies who are not receiving the attention that they merit, using detailed commentary, appropriate valuation metrics and regular publications to help eradicate undervaluation in the medium term.
Search for Company Research
FREE REGISTRATION
Sign up today and access the very latest company research
LOG IN
For access to all company research please
Most Recent Company Documents
Minoan Group
The Final Hurdle
£1.4m placing should ensure sufficient cash to start of Cavo Sidero project
New Greek National Land Plan favourable to Minoan
Target price reduced to reflect more conservative assumptions but, at 180p / share, is still much higher than the current price of 30p
Retec Digital
Well positioned for growth
Impressive customer list
NCR on board as a channel partner
Share price target 5p vs current 2p
Healthcare Locums
Trading update affirms a genuine special situation among challenged recruitment shares
28% growth in net fee income over three months
All 3 UK divisions experiencing increasing demand
Forecasts upgraded
York Pharma
Strategic acquisition
Enlarges product portfolio
Group now less reliant on approval of in-house products
Recent corporate transaction highlights significant value
Hydrodec Group
Addressing huge market to re-refine oil
Patented process for re-refining transformer oil
US plant being commissioned
Base case DCF shows fair value 108p / share, versus 51p now
